Daniel Clark
Stock Analyst at Leerink Partners
(2.94)
# 1,609
Out of 5,053 analysts
7
Total ratings
80%
Success rate
32.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $709.59 | -15.44% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $119.79 | +29.39% | 2 | Jul 17, 2025 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $18 | $22.27 | -19.17% | 2 | Jul 17, 2025 |
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $709.59
Upside: -15.44%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $119.79
Upside: +29.39%
Elanco Animal Health
Jul 17, 2025
Upgrades: Outperform
Price Target: $18
Current: $22.27
Upside: -19.17%